Logo
mildlycomet
22 hours ago
Artificial intelligence is moving at a pace that would have seemed impossible just a few years ago. New models arrive every few months. Computing requirements keep rising. Companies across health care, finance, manufacturing, and software are racing to adopt AI before competitors gain an edge. But what happens when the technology advances faster than the infrastructure supporting it?
That's the question investors should be asking about Nvidia (NVDA). The AI leader has spent the last three years setting the pace for the industry. Yet as CEO Jensen Huang unveils increasingly powerful products, a new concern is emerging: Nvidia may be accelerating faster than memory suppliers, electric utilities, and even customers can keep up.
Dear Microsoft Stock Fans, Mark Your Calendars for June 2
Microsoft Stock Is Up Nearly 30% From Its March Lows, But You Shouldn’t Sell MSFT Just Yet
Dell Stock Could Be Worth 30% More - Based on Strong AI Demand and FCF
mildlycomet
1 day ago
Okta (OKTA) has gone from a forgotten software name to one of the market’s loudest AI security stories in a matter of weeks. That is saying something in 2026, because software stocks have been battling a simple fear. Investors keep asking whether AI will eat the software world or help the right software names grow faster. Okta is landing in the second camp. The company helps manage identity, access, and security. That makes it a natural fit for a world where people are not the only users anymore. AI agents are showing up, too. And that is exactly the story investors loved when Okta reported earnings and the stock jumped about 30% to a 52-week high, after a long stretch of doubt earlier this year.
That signals the turnaround story for the software company has finally begun.
Dear Microsoft Stock Fans, Mark Your Calendars for June 2
Microsoft Stock Is Up Nearly 30% From Its March Lows, But You Shouldn’t Sell MSFT Just Yet
Dell Stock Could Be Worth 30% More - Based on Strong AI Demand and FCF
mildlycomet
2 days ago
SpaceX’s (NASDAQ:SPCX) upgraded Starship launch on Friday delivered enough progress to reinforce investor confidence ahead of Elon Musk’s planned $1.75 trillion IPO, even though the test also highlighted that achieving full rocket reusability remains an unfinished challenge.
Starship plays a central role in ***** eX’s long-term strategy to reduce launch costs, expand its Starlink satellite network — currently the company’s main revenue generator — and support future ambitions including orbital AI data centers, ***** e-based computing infrastructure and crewed missions to the Moon and potentially Mars.
“SpaceX did not need perfection from this Starship flight. It needed proof that the upgraded vehicle is moving in the right direction, and that is largely what investors saw,” said Mark Vena, CEO at SmartTech Research.
SpaceX has already invested more than $15 billion into the development of Starship, which the company hopes will eventually become a fully reusable launch system capable of transporting payloads far larger than existing rockets.
Friday’s mission marked the 12th Starship prototype test flight since 2023 and the first involving the new V3 version of the vehicle. The launch achieved several important objectives, including the deployment of mock satellites and a controlled splashdown of the ***** ecraft in the Indian Ocean. However, the Super Heavy booster failed to complete a controlled landing and instead crashed into the Gulf of Mexico.
mildlycomet
2 days ago
Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company has a market capitalization of $65 billion and develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases, as well as cancer and more.
Companies with a market cap of $10 billion or more are typically referred to as “big-cap stocks.” REGN fits squarely into that category, with its market cap exceeding this threshold and reflecting its substantial size and influence in the biotechnology industry.
Barclays Says Sandisk’s New AI Contracts Could Change the Memory Industry
Meta Has a Plan to Monetize Its AI Investments. Its Underperforming Stock Needs It Badly.
Why Warren Buffett Hasn’t Sold Coca-Cola Stock for Over 30 Years